Results 141 to 145 of about 3,260 (145)

Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies

Advances in Therapy, 2022
SuJun Gao, Haiwen Huang, Jianyong Li
exaly  

A fatal disseminated cryptococcal infection in a patient treated with zanubrutinib for Waldenström’s macroglobulinemia

Journal of Oncology Pharmacy Practice, 2022
Constantin A Dasanu, Dave Patel
exaly  

Nonclinical Safety Assessment of Zanubrutinib: A Novel Irreversible BTK Inhibitor

International Journal of Toxicology, 2020
Cuining Zhang
exaly  

Top bar navigation

Frontiers in Oncology, 2022
exaly  

Safety study on adverse events of zanubrutinib based on WHO-VigiAccess and FAERS databases

Expert Opinion on Drug Safety
exaly